TTop stories Read More Hims & Hers won’t sell compounded version of Novo’s obesity pillFebruary 8, 2026 Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version…
HHeadlines Read More Cost of new food pyramid tested by economists. Results are mixedJanuary 16, 2026 How easy is it to make a healthy dinner for $3? When the new U.S. dietary guidelines came…
TTop stories Read More Trump signs a law returning whole milk to school lunchesJanuary 15, 2026 Whole milk is heading back to school cafeterias across the country after President Donald Trump signed a bill…
TTop stories Read More Trump signs law returning whole milk to school lunchesJanuary 15, 2026 Whole milk is heading back to school cafeterias across the country after President Donald Trump signed a bill…
HHeadlines Read More Novo’s Wegovy pill to test demand from consumers with cash – The Irish TimesDecember 23, 2025 Novo Nordisk’s newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying…
HHeadlines Read More US approves pill version of blockbuster weight-loss drug WegovyDecember 23, 2025 By Euronews with AP Published on 23/12/2025 – 11:10 GMT+1 Regulators in the United States gave the green light to a…
HHeadlines Read More Pill version of Novo Nordisk’s Wegovy approved, possibly widening accessDecember 23, 2025 The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug…
HHeadlines Read More World Health Organization recommends Ozempic-style medications as long-term obesity treatmentsDecember 2, 2025 Ozempic-style medications have been endorsed as long-term treatments for obesity under new guidelines released by the World Health…
HHeadlines Read More Will blockbuster obesity drugs revolutionize addiction treatment?December 2, 2025 Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction…
TTop stories Read More Novo Nordisk Stock Slumps After Ozempic Pill Fails in Alzheimer’s TrialsNovember 25, 2025 Novo Nordisk NOVO.B 3.80%increase; green up pointing triangle shares fell sharply after the Danish drugmaker said a pill…
HHeadlines Read More Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo NordiskNovember 8, 2025 Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning…
TTop stories Read More Uncommon Knowledge: Trump’s Obesity Fix—SNAP Bans and Subsidized DrugsNovember 7, 2025 The price tag in the pharmacy is falling. In the grocery aisle, the rules are tightening. The Trump…